Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
romidepsin multidrug resistance-associated protein 1 small molecule NA drugbank Lymphoma
T-Cell
Cutaneous[MeSHID:D016410]
Continuance of life[MeSHID:D013534]
Peripheral T-Cell Lymphoma[MeSHID:D016411]
Renal Cell Carcinoma[MeSHID:D002292]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA approved,investigational unknown
romidepsin histone deacetylase 1 small molecule Successful target TTD , drugbank , DGIDB Lymphoma
T-Cell
Cutaneous[MeSHID:D016410]
Continuance of life[MeSHID:D013534]
Peripheral T-Cell Lymphoma[MeSHID:D016411]
Renal Cell Carcinoma[MeSHID:D002292]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.54 approved,investigational antagonist,inhibitor
romidepsin histone deacetylase 2 small molecule NA drugbank , DGIDB Lymphoma
T-Cell
Cutaneous[MeSHID:D016410]
Continuance of life[MeSHID:D013534]
Peripheral T-Cell Lymphoma[MeSHID:D016411]
Renal Cell Carcinoma[MeSHID:D002292]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.47 approved,investigational antagonist,inhibitor
romidepsin histone deacetylase 4 small molecule NA drugbank , DGIDB Lymphoma
T-Cell
Cutaneous[MeSHID:D016410]
Continuance of life[MeSHID:D013534]
Peripheral T-Cell Lymphoma[MeSHID:D016411]
Renal Cell Carcinoma[MeSHID:D002292]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.42 approved,investigational inhibitor
romidepsin histone deacetylase 6 small molecule NA drugbank , DGIDB Lymphoma
T-Cell
Cutaneous[MeSHID:D016410]
Continuance of life[MeSHID:D013534]
Peripheral T-Cell Lymphoma[MeSHID:D016411]
Renal Cell Carcinoma[MeSHID:D002292]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.53 approved,investigational inhibitor
click here to return to the previous page